Crescendo Venture Partners, an Israeli venture fund, led the financing round, with additional participation from Industry Ventures, an American venture capital fund, and existing investors, including Vertex and Angular Ventures.
The Datos Health software platform simplifies remote healthcare treatments, follow-ups and facilitates remote care connecting patients – from their homes – with healthcare providers. The platform monitors and predicts adverse health events in real-time, enabling physicians and care teams to communicate and intervene to manage complex medical treatments.
“The coronavirus pandemic has served as an unwitting catalyst for transforming healthcare systems around the world at a remarkable pace. The demand for data-driven patient engagement and home hospitalization solutions is increasing rapidly, as hospitals seek to optimize resources and manage huge influxes of patients,” said Yuval Avni, Managing General Partner at Crescendo Venture Partners. “The Datos team has responded to the current crisis, and the impressive early market adoption of its platform has confirmed to us that its approach to patient care and data handling can significantly support the needed shift to home hospitalization.”
Datos Health plans to use new funds to expand sales and marketing efforts, accelerate product development, and acquire new talents.
Recently this year, AlayaCare, a provider of remote patient monitoring software solutions, raised another $37 million in Series C round from Caisse de dépôt et placement du Québec (CDPQ) and iNovia Capital. In another deal, CloudCath, a provider of a remote monitoring platform for catheter-based treatments, secured $12 million in Series A financing, which was led by Capital Integral, with participation from FundRx, The Capital Partnership, Coconut Tree Investments, and Stanford University’s StartX Fund.
Seventy-five remote patient monitoring companies raised $700 million since 2013, according to Mercom data.